|
|
|
41
|
A322LV
|
EFFEXOR 150MG XR CAP (PFI) VENLAFAXINE (C)
|
VENLAFAXINE
|
EFFEXOR
|
28'S
|
C
|
136.81
|
4.8862
|
CAPXR
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
41
|
A322LX
|
FLUNIL 20MG CAP (INP) FLUOXETINE
|
FLUOXETINE
|
FLUNIL
|
3X10
|
A
|
2.39
|
0.0797
|
CAP
|
42
|
BOX
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A322MA
|
APO-ESCITALOPRAM 20MG TAB (APO)
|
ESCITALOPRAM
|
APO-ESCITALOPRAM
|
100'S
|
C
|
29.96
|
0.30
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A322ML
|
FLUOXETINE 20MG CAP (HEA)
|
FLUOXETINE
|
FLUOXETINE
|
10X10
|
A
|
5.30
|
0.05
|
CAP
|
120
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2025-10-31
|
|
|
|
42
|
A322MM
|
ZOLOFT 100MG TAB (PFI) SERTRALINE
|
SERTRALINE
|
ZOLOFT
|
14'S
|
C
|
37.54
|
2.68
|
TAB
|
42
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
COL
|
AVENTA BARBADOS
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A322MX
|
LEEPAROX 25MG SR TAB (JLP) PAROXETINE
|
PAROXETINE
|
LEEPAROX
|
10X10
|
BP
|
13.59
|
0.14
|
TAB
|
0
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
|
|
|
|
42
|
A322NA
|
FLUOXETINE 20MG CAP (HEA)
|
FLUOXETINE
|
FLUOXETINE
|
10X10
|
A
|
5.30
|
0.05
|
CAP
|
120
|
BLIS
|
HEA
|
HEALTH 2000 INC
|
CWS
|
CAPSULE WHOLESALE
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-01-26
|
|
|
|
42
|
A322NB
|
FLUOXETINE 20MG CAP (HEA)
|
FLUOXETINE
|
FLUOXETINE
|
10X10
|
A
|
5.30
|
0.05
|
CAP
|
120
|
|
HEA
|
HEALTH 2000 INC
|
STO
|
BRYDEN STOKES LTD
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2026-02-27
|
|
|
|
42
|
A3313
|
AAP-MOCLOBEMIDE 150MG TAB (APO)
|
MOCLOBEMIDE
|
AAP-MOCLOBEMIDE
|
100'S
|
C
|
26.10
|
0.26
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28160412
|
MONOAMINE OXIDASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
MONOAMINE OXIDASE INHIBITORS
|
|
|
|
|
41
|
A3421
|
PACLITAXEL 6MG/ML INJ (FSB) (BQ)
|
PACLITAXEL
|
PACLITAXEL
|
50ML
|
BQ
|
53.44
|
53.4422
|
VIAL
|
25
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
A3425
|
CYTAX 6MG/ML INJ (INP/AHI) PACLITAXEL
|
PACLITAXEL
|
CYTAX
|
50ML
|
BQ
|
114.17
|
114.17
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
A3428
|
PACLITAXEL 6MG/ML INJ (KWA) (BQ)
|
PACLITAXEL
|
PACLITAXEL
|
50ML
|
BQ
|
63.77
|
63.7719
|
VIAL
|
25
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
A342AM
|
PACLITOXIN 6MG/ML INJ (JLP) PACLITAXEL
|
PACLITAXEL
|
PACLITOXIN
|
50ML
|
BQ
|
43.49
|
43.49
|
VIAL
|
25
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
A342B
|
PACLITAXEL 6MG/ML INJ (KWL/RXP)
|
PACLITAXEL
|
PACLITAXEL
|
50ML
|
BQ
|
88.62
|
88.62
|
INJECTION
|
0
|
VIAL
|
KWL
|
KHANDELWAL LABS
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
A342E
|
ZAXOL 6MG/ML INJ (ZUV) PACLITAXEL
|
PACLITAXEL
|
ZAXOL
|
50ML
|
BQ
|
64.48
|
64.4786
|
VIAL
|
25
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
2024-02-08
|
|
|
|
42
|
A342E
|
ZAXOL 6MG/ML INJ (ZUV) PACLITAXEL
|
PACLITAXEL
|
ZAXOL
|
50ML
|
BQ
|
42.62
|
42.62
|
VIAL
|
25
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
A3611
|
ARCALION 200MG TAB (SER/STO) SULBUTIAMINE
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
23.73
|
1.19
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A3611
|
ARCALION 200MG TAB (SER) SULBUTIAMINE (C)
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.2232
|
TAB
|
0
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
A3611
|
ARCALION 200MG TAB (SER) SULBUTIAMINE
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.22
|
TAB
|
0
|
BLIS
|
SER
|
LES LABORATOIRES SERVIER
|
STO
|
BRYDEN STOKES LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A3612
|
ARCALION 200MG TAB (SER/COL) SULBUTIAMINE
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
23.73
|
1.19
|
TABLET
|
0
|
TAB
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
